Canada - English - Health Canada

pharmel inc - famciclovir - tablet - 500mg - famciclovir 500mg - nucleosides and nucleotides

Canada - English - Health Canada

apotex inc - famciclovir - tablet - 250mg - famciclovir 250mg - nucleosides and nucleotides

Canada - English - Health Canada

apotex inc - famciclovir - tablet - 500mg - famciclovir 500mg - nucleosides and nucleotides

Canada - English - Health Canada

auro pharma inc - famciclovir - tablet - 250mg - famciclovir 250mg - nucleosides and nucleotides

Canada - English - Health Canada

auro pharma inc - famciclovir - tablet - 500mg - famciclovir 500mg - nucleosides and nucleotides

Canada - English - Health Canada

cobalt pharmaceuticals company - famciclovir - tablet - 125mg - famciclovir 125mg - nucleosides and nucleotides

United States - English - NLM (National Library of Medicine)

avkare, inc. - famciclovir (unii: qic03ani02) (penciclovir - unii:359hue8fjc) - famciclovir 125 mg - herpes labialis (cold sores): famciclovir tablets are indicated for the treatment of recurrent herpes labialis. genital herpes: recurrent episodes: famciclovir tablets are indicated for the treatment of recurrent episodes of genital herpes. the efficacy of famciclovir tablets when initiated more than 6 hours after onset of symptoms or lesions has not been established. suppressive therapy: famciclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes. the efficacy and safety of famciclovir tablets for the suppression of recurrent genital herpes beyond 1 year have not been established. herpes zoster (shingles): famciclovir tablets are indicated for the treatment of herpes zoster. the efficacy of famciclovir tablets when initiated more than 72 hours after onset of rash has not been established. recurrent orolabial or genital herpes: famciclovir tablets are indicated for the treatment of recurrent episodes of orolabial or genital herpes in hiv-infected adults. the

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - famciclovir, quantity: 125 mg - tablet, film coated - excipient ingredients: silicon dioxide; crospovidone; microcrystalline cellulose; copovidone; sodium stearylfumarate; titanium dioxide; macrogol 8000; hypromellose; polydextrose; triethyl citrate - famciclovir is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours.,efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster infection is generally a milder condition in younger patients. famciclovir is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.,famciclovir is also indicated for suppression of recurrent genital herpes.,famciclovir is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,famciclovir is also indicated in immunocompromised patients for: ? treatment of uncomplicated herpes zoster ? treatment of recurrent herpes simplex ? suppression of recurrent herpes simplex

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - famciclovir -

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - famciclovir -